Inventor · disambiguated record
Michael Oberst
Also filed as: OBERST MICHAEL · OBERST MICHAEL DAVID
6 granted patents·7 pending applications·36 citations·filing 2002–2024
80Inventor score
Top patents by PatentIndex Score
13 records- 0194US9738723B2Humanized anti-OX40 antibodies and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 22, 2017·20 cites·24 claims
- 0293US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0389USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 0489US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 0587US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0675US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 0768US9718870B2OX40L fusion proteins and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 1, 2017·1 cites·36 claims
- 0856US10150815B2Method of treating cancer with humanized anti-OX40 antibodiesMEDIMMUNE LLC·Filed 2017·Granted Dec 11, 2018·0 cites·8 claims
- 0956US2019169303A1Humanized Anti-OX40 Antibodies and Uses ThereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 1044US2019241659A1Bispecific fusion polypeptides and methods of use thereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 1139US2003170245A1Activation of matriptase and diagnostic and therapeutic methods based thereonFiled 2002·Application pending·0 cites
- 1238US2013035249A1Methods and compositions for detecting and treating cea-expressing cancersMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 1335US2016347848A1Therapeutic combinations and methods for treating neoplasiaMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Oberst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →